A phase 2 clinical trial of AP23573, an mTOR inhibitor, In patients with relapsed or refractory hematologic malignancies

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Rizzieri, DA; Feldman, E; Moore, JO; Roboz, GJ; DiPersio, JF; Gabrail, N; Stock, W; Rivera, VM; Albitar, M; Bedrosian, CL; Giles, F

Published Date

  • November 16, 2005

Published In

Volume / Issue

  • 106 / 11

Start / End Page

  • 835A - 836A

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 47th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • Atlanta, GA

Conference Start Date

  • December 10, 2005

Conference End Date

  • December 13, 2005